Issuance of Performance-Based Stock Options
First written in FY2017-Q2. 3 of 9 entries say "Advanced", first in FY2019. Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022DroppedAnnual report
「All of these stock acquisition rights have expired because the performance conditions were not met.」
All 396,000 shares under the second Medium-Term Plan-linked stock acquisition rights resolved in November 2019 expired because the condition of consolidated operating profit of at least ¥2.6 billion was not met. - FY2021First issue expired; second issue not yet vestedAnnual report
「All 86,000 unexercised shares under the stock acquisition rights resolved on 11 November 2016 expired after vesting. The 396,000 unvested shares under the stock acquisition rights resolved on 11 November 2019 remained unvested.」
The remaining first-issue Medium-Term Plan-linked stock options expired, while the second issue remained unvested for 396,000 shares before the exercise period began in May 2022. - FY2020AdvancedAnnual report
「After vesting (shares) End of previous consolidated fiscal year — Vested 240,000 Exercised 152,000 Expired 2,000 Unexercised balance 86,000」
Under the first Medium-Term Plan-linked stock acquisition rights, 240,000 shares vested and 152,000 shares were exercised. The remaining 86,000 shares were disclosed, indicating further progress in the exercise of the performance-linked stock options. - FY2020-Q3AchievedAnnual report
「The stock acquisition rights issued during the third quarter accounting period were as follows. Number of stock acquisition rights (rights)*: 3,960 (Note 1). Class, description and number of shares underlying the stock acquisition rights (shares)*: common shares, 396,000 (Note 1). Exercise period for the stock acquisition rights*: 23 May 2022 to 19 May 2023.」
For the performance-conditioned stock acquisition rights, 3,960 rights covering 396,000 shares were allotted to 9 directors and 90 employees on 26 November 2019, completing the issuance. - FY2020-Q2AdvancedAnnual report
「At the company’s 58th Annual General Meeting of Shareholders held on 25 June 2019, approval was given for the issuance of stock acquisition rights to the company’s directors, excluding outside directors, and employees under Articles 236, 238 and 239 of the Companies Act. The specific terms were determined at the Board of Directors meeting held on 11 November 2019 as follows. The stock acquisition rights carry performance conditions and may be exercised only if consolidated operating profit of at least ¥2.6 billion is achieved in the final year of the company’s Medium-Term Plan 2021, the fiscal year ended March 2022.」
For the stock acquisition rights approved at the 58th Annual General Meeting of Shareholders, the company determined the specific issuance terms for 3,960 rights covering 396,000 shares to 9 directors and 90 employees. The rights were subject to a performance condition requiring consolidated operating profit of at least ¥2.6 billion in the final year of Medium-Term Plan 2021, and the exercise period was set from 23 May 2022 to 19 May 2023. - FY2019AdvancedAnnual report
「At the 58th Annual General Meeting of Shareholders held on 25 June 2019, the company resolved to issue 3,990 stock acquisition rights covering 399,000 common shares to 9 directors and 91 employees. The stock acquisition rights carry performance conditions, and the exercise period is from 23 May 2022 to 19 May 2023.」
For the performance-conditioned stock options, the company resolved to issue 3,990 rights covering 399,000 shares and set an exercise period beginning in 2022. - FY2017RestatedAnnual report
「Multiple performance conditions will be attached to the allocated stock acquisition rights. All of the rights may be exercised only if all such conditions are met. If the conditions are not met, some or all of the rights may not be exercised, depending on the extent to which they are unmet.」
The company reconfirmed the 2,400 performance-conditioned stock acquisition rights, the 240,000 underlying shares and the exercise period beginning in May 2019. - FY2017-Q3RestatedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
The company reiterated the 2,400 stock acquisition rights resolved on 11 November 2016, the 240,000 underlying shares, the multiple performance conditions and the exercise period beginning on 21 May 2019. - FY2017-Q2First statedAnnual report
「Multiple performance conditions will be attached to the allocated stock acquisition rights. All of the rights may be exercised only if all such conditions are met. If the conditions are not met, some or all of the rights may not be exercised, depending on the extent to which they are unmet.」
The company issued 2,400 stock acquisition rights covering 240,000 common shares to a total of 88 directors and employees. The allotment date was 25 November 2016, and the exercise period ran from 21 May 2019 to 20 May 2020. Multiple performance conditions were attached.